Industry
Biologics
Vaccines, antibodies, biosimilars, blood and plasma products: licences, label changes, safety reviews and the guidance behind them.
60 stories
Regulatory News has published 60 Biologics stories between 26 July 2026 and 1 November 2026, each sourced to the primary record — the Federal Register entry, the Official Journal notice, the guidance document or the regulator’s own release — and written and edited by Connor Griggs, the publication’s editor. Last updated 1 November 2026.
All coverage
60 stories, newest first.
Search within Biologics coverage, or narrow it further.
Showing 60 of 60 stories
No stories match that search — yet.